OvaScience, Inc., a pioneering biotechnology company headquartered in the United States, focuses on advancing reproductive health through innovative solutions. Founded in 2011, OvaScience has made significant strides in the field of fertility, particularly with its proprietary technology aimed at enhancing egg quality and quantity for women facing infertility challenges. The company’s core offerings include the AUGMENT™ treatment, which utilises a woman’s own egg precursor cells to improve the chances of successful conception. This unique approach sets OvaScience apart in the competitive fertility industry, positioning it as a leader in reproductive science. With a commitment to research and development, OvaScience continues to explore new avenues for improving reproductive outcomes, solidifying its reputation as a key player in the global fertility market.
We don't have data for OvaScience, Inc., but we can show you information about their parent organization instead.
View parent company